Examination of the Polymicrobial Interaction:  Inhibitory Effects of Alcaligenes Species on Members of the Candida Species by Whitlock, Madelyn
East Tennessee State University 
Digital Commons @ East Tennessee State University 
Undergraduate Honors Theses Student Works 
5-2020 
Examination of the Polymicrobial Interaction: Inhibitory Effects of 
Alcaligenes Species on Members of the Candida Species 
Madelyn Whitlock 
Follow this and additional works at: https://dc.etsu.edu/honors 
 Part of the Other Public Health Commons 
Recommended Citation 
Whitlock, Madelyn, "Examination of the Polymicrobial Interaction: Inhibitory Effects of Alcaligenes Species 
on Members of the Candida Species" (2020). Undergraduate Honors Theses. Paper 537. 
https://dc.etsu.edu/honors/537 
This Honors Thesis - Withheld is brought to you for free and open access by the Student Works at Digital Commons 
@ East Tennessee State University. It has been accepted for inclusion in Undergraduate Honors Theses by an 





Examination of the Polymicrobial Interaction:  
Inhibitory Effects of Alcaligenes Species on Members of the Candida Species 
By 




An Undergraduate Thesis in Fulfillment of 
 the Requirements for the  
Midway Honors Program 
College of Public Health 
Honors College   




      __________________________________________ 




      __________________________________________ 
      Dr. Sean James Fox, Thesis Director  Date 
      
       
       
 
 
Sean James Fox 4/22/2020 
MADELYN WHITLOCK 2 
 













Alcaligenes faecalis causes a morphological change in Candida albicans cells	.............................................	10	
Alcaligenes faecalis does not cause a morphological change in Candida glabrata	.......................................	12	
Candida mutations in adhesion molecules resists morphological changes caused by A. faecalis	............	14	
Alcaligenes viscolactis does not cause a morphological change in C. albicans	.............................................	15	
A. faecalis significantly inhibits both C. albicans and C. glabrata growth in 24h planktonic cocultures 
as evidenced by colony forming units (CFUs).	.........................................................................................................	18	
A. viscolactis significantly inhibits both C. albicans and C. glabrata growth in 24h planktonic 
cocultures as evidenced by colony forming units (CFUs).	....................................................................................	20	










MADELYN WHITLOCK 3 
 
Abstract 
 Candida species are commonly found in the human normal flora, however they are a 
major cause of nosocomial infections that can be life threatening. This fungal species is an 
opportunistic pathogen and causes infection in individuals who are immunosuppressed.  A key 
characteristic of Candida’s virulence is the ability to change its morphology from ovoid yeast to 
filamentous hyphae. Alcaligenes species are common bacteria found in the environment that 
rarely, if at all, cause infections in humans.  It has been observed that when allowed to interact, 
Alcaligenes faecalis changes the morphology of Candida albicans from yeast cells to hyphal 
cells.  When A. faecalis interacts with Candida glabrata or a mutated C. albicans, it causes no 
change in morphology and the cells are all in the yeast morphology.  When allowed to interact 
with C. albicans and the mutated C. albicans, Alcaligenes viscolactis did not cause any changes 
in morphology to either type with all cells staying in the yeast form.  Interestingly, however, both 
A. faecalis and A.s viscolactis both inhibited C. albicans and C. glabrata which was 
demonstrated on both agar plate interactions and liquid co-cultures.  A. faecalis showed a greater 
inhibitory effect than A.viscolactis.  The concentration of A. faecalis does not seem to be a 
contributing factor to the inhibitory effect it has on both C. albicans and C. glabrata. Taken 
together, these results demonstrate that A. faecalis and A. viscolactis could potentially be used to 
control one of the key virulence traits of C. albicans and could potentially identify new areas of 
study in Prokaryotic-Eukaryotic interactions, as well as, potential targets for treatment of C. 
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Microbes are everywhere and are amazingly diverse.  The human body is covered with 
microbes from the external skin to the internal lining of the digestive system where they serve 
many functions depending on where on the body the body they are found (10).  Microbes can be 
an important advantageous part of the body, serving vital functions such as fighting infections 
and inhibiting pathogens (10).  Some of the microbes that the human body is exposed to are 
pathogenic leading to infections.  Some microbes are opportunistic pathogens which only cause 
problems when the human body is immunosuppressed and weak.  Before antibiotics, bacterial 
infections were more often deadly leading to high mortality and morbidity rates.  With the 
discovery and development of penicillin, healthcare completely changed.  Antibiotics are an 
effective treatment for bacterial infections, but they must be used carefully.  Antibiotics, like 
penicillin, have been used in excess to treat illness. Microbes are highly reactive to changes in 
the environment.  They can easily and quickly evolve to thrive in new environmental conditions.  
Antibiotics can have a broad spectrum or narrow spectrum effect and when they are misused can 
have major consequences.  The excessive use of broad spectrum antibiotics have led to high 
levels of antibiotic resistant bacteria and are progressively more difficult to treat.  The rise of 
antibacterial resistant bacteria has caused researchers to attempt to understand alternative 
methods to inhibit pathogenic bacteria. Bacteria are living cells that require nutrients and space 
to survive, thus they constantly have to compete with other bacteria to thrive.  Microbes interact 
with other microbes in both antagonistic and mutualistic ways, an area of which we know very 
little about.  
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Candida Species:  
Candida albicans: 
 Candida albicans is a dimorphic fungus and a prevalent opportunistic pathogen, but is 
also commonly a part of the human microbiome (10).  This fungi causes infections when 
individuals are immunosuppressed or when the immune system is compromised in some other 
way.  C. albicans normally live in the gut, the genito-urinary tract, and the skin (4). Causing a 
variety of infections that can be mild like oral thrush, fungal urinary tract infections, genital yeast 
infections, or mucocutaneous candidiasis (13).  Other infections that are caused by this fungi can 
be more serious and life threatening when it enters the bloodstream.  These infections include 
candidemia, fungal endocarditis, endophthalmitis, fungal meningitis, and many others (13).  This 
microbe is resistant to treatment through antifungals due to the many virulence factors it contains 
and to the biofilms it produces (4)(5).  Biofilms are caused by microbial attachment to surfaces 
and to each other which makes them more likely to cause infection and increases resistance to 
treatment (6).  This fungus is highly reactive to the environment which increases its resistance to 
antifungal treatments (3).  This microbe also has been known to interact with different bacteria 
found on the body (10)(14).  Due to the pathology of C. albicans, it is one of the most common 
causes of nosocomial infections.   C. albicans transition between three different morphological 
forms which are yeast, pseudohyphal, and hyphal.  It can form budding yeast which are round 
large cells.  The fungi can undergo metamorphism and develop into Pseudohyphae which 
appears to be round cells with long branches sprouting from the cell.  The hyphae form is a long 
spindle like cell.  The virulence of C. albicans is connected to the morphological state of the 
fungi (12).  The ability of C. albicans to transition between these morphological traits is key to 
its virulence as C. albicans that are locked into any one morphology lose their virulence 
potential. 
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Candida glabrata: 
Candida glabrata is similar to C. albicans in the fact that they are both commonly found 
in normal human flora and that they are both opportunistic pathogens (8).  This fungi is found on 
the skin and in the body like the mouth and vagina (8).  It can cause significant infections similar 
to C. albicans including life-threatening bloodstream infection (8).  This fungi also produces 
biofilms which, like C. albicans, causes it to be more resistant to antifungal treatments (8).  This 
microbe has key differences to C. albicans.  C. glabrata is significantly smaller to C. albicans 
with C. glabrata being 1-4µm and C. albicans being 4-6µm (8).  This fungus is not as virulent as 
C. albicans although it closely follows as the second most common cause of nosocomial fungal 
bloodstream infections (8).  C. glabrata is different in morphology and stays in the budding yeast 
form (8).  It does not develop into the hyphal morphology although under particular stress 
conditions it can develop into pseudohyphal (8).  Another difference is that this fungus is not as 
reactive to the environment as C. albicans (7).  C. glabrata is a haploid microorganism while C. 
albicans is diploid (8).  The interaction between the human immune system and C. glabrata is 
not very well understood.  However, C. glabrata interacts with macrophages interestingly as it 
can survive and continue to replicate inside of macrophages without causing damage to the 
immune cell (8).  It is believed that macrophages can act as “trojan horses” for C. glabrata 
infections which increases its virulence (8).  It is also understood that C. glabrata has innate 
azole resistance (8).             
Alcaligenes Species:  
Alcaligenes faecalis: 
 Alcaligenes faecalis is a bacteria that is commonly found in the soil and water (2).  It is 
also commonly found in hospitals and the human body specifically in the normal flora of the 
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intestinal tract (15).   This bacteria is Gram-negative bacillus and it is aerobic nonfermentative 
(15).  A. faecalis is unusual as most Gram-negative bacteria are anaerobic (2).  This 
microorganism is important ecologically as it has significant abilities to clean up after oil spills 
(2).  It can also metabolize arsenite and change it into arsenate which is useful to neutralize 
contaminated environments (2).  A. faecalis is an opportunistic pathogen and rarely causes 
infections (15).  It has often been found from fluids associated with open wounds and in the ear 
(2).  This bacteria can cause infection in individuals with compromised and suppressed immune 
systems.  These infections are most often to occur in the hospital due to contaminated hospital 
equipment and body fluids (15).  Although this bacteria has been found to cause infection in both 
humans and in birds, the virulent pathway of this bacteria is largely unknown (2). 
Alcaligenes viscolactis: 
Alcaligenes viscolactis is extremely similar to A. faecalis as both are aerobic, 
nonfermentative bacilli.  Like most members of Alcaligenes, this bacteria is also commonly 
found in the soil and in water (1).  It is an opportunistic pathogen and rarely causes infection (1).  
A. viscolactis is found in milk and causes the milk to develop a ropy texture (9).  This bacteria is 
also known to use amino acids, specifically L-Proline and L-Tyrosine, for growth and the 
production of slime (11).  Not much more is known about this bacterium.  
Methods 
Microbial Strains and Culture Conditions. C. albicans and C. glabrata strains were 
maintained on Yeast Peptone Dextrose (YPD) agar plates and broth and grown at 37⁰ C with 
shaking (250rpm) while A. faecalis and A. viscolactis were maintained on Luria Bertani (LB) 
agar and broth and grown at 37⁰ C and 30⁰ C respectively. For co-cultures, Brain Heart Infusion 
(BHI) broth and agar were used. 
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Quantitation of Morphological Changes. Candida and Alcaligenes strains were inoculated into 
their respective broth media and incubated at 37⁰ C or 30⁰ C overnight with shaking (250rpm). 
Overnight cultures were used as starter cultures to make mono and cocultures in the appropriate 
broth media by adding 50µl of the Candida species and 150µl of the Alcaligenes species. The 
mono and cocultures were then incubated for 4 hours at 37⁰ C or 30⁰ C. After the 4 hour 
incubation period, 20µl of the mono or the coculture were added to a microscope slide and 
observed using a Zeiss Primostar light microscope using the 100X objective.  The number of 
yeast, pseudohyphal, and hyphal cells were counted from multiple representative fields on the 
microscope until the combined number reached 50 total cells.   
Coculture Colony Forming Units (CFU) Candida and Alcaligenes strains were inoculated into 
their respective broth media and incubated at 37⁰ C or 30⁰ C overnight with shaking (250rpm). 
Overnight cultures were used as starter cultures to make mono and cocultures in the appropriate 
broth media. The optical density (OD600) of each starter culture was determined and used to 
equilibrate the amount of inoculum to use. Candida strains were inoculated to a concentration of 
~1x106 cells/ml and Alcaligenes strains were inoculated to a concentration of ~1x108 cells/ml. 
The mono and coculture tubes were incubated for 24 hours with shaking at either 37⁰ C or 
30⁰ C. Culture tubes were then serially diluted and plated on LB agar plates supplemented with 
50µg/ml Kanamycin. LB agar plates were then incubated for an additional 24 hours, monitored 
for growth, and CFUs enumerated. 
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Zones of Inhibition Candida and Alcaligenes strains were inoculated into their respective broth 
media and incubated at 37⁰C or 30⁰C overnight with shaking (250rpm). Candida lawns were 
created on agar plates by taking a sterile Q-tip and spreading confluently over the surface of the 
plate. To four different microcentrifuge tubes, 1000µl of overnight cultures of Alcaligenes was 
added and centrifuged for five minutes at 10K rpm.  The remaining liquid was decanted into a 
waste beaker, varying amounts of fresh LB broth was added (500µl, 250µl, 125 µl, and 65 µl), 
vortexed thoroughly to resuspend the bacterial cells, and 20µl of the new mixtures were spotted 
onto the Candida lawns.  These agar plates were incubated at 37 or 30 for 24 hours.  The 
following day, the zones of inhibition that had developed around the spots of Alcaligenes were 
measured.  
Results 
Alcaligenes faecalis causes a morphological change in Candida albicans cells 
The yeast form of C. albicans is important for colonization and dissemination while the 
hyphal form of C. albicans is important for invasion and immune system evasion.  Prior work in 
our laboratory has demonstrated that all three morphological forms of C. albicans are inhibited 
by A. faecalis, however A. faecalis inhibits the hyphal form at a higher rate than the other two 
forms. We therefor wanted to closely examine the morphological state of C. albicans when 
grown in monoculture verses co-culture with Alcaligenes. When C. albicans grew planktonically 
independent from any other bacteria, it grew primarily in the yeast form with minimal 
pseudohyphal or hyphal forms.  When C. albicans was allowed to interact with A. faecalis in 
planktonic culture, it had a significant change in morphology from dominantly yeast form to 
primarily the hyphal form. This evidences that a major way A. faecalis could inhibit C. albicans 
is by causing it to change morphology to its hyphal form which may be more susceptible to the 
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physical interactions and inhibition that A. faecalis exerts upon it.  In the control of pure C. 
albicans, it was observed that most of the Candida cells were in the yeast morphology (66%) 
with fewer cells in the pseudohyphal (17.4%) and hyphal (16.6%) form (Table 1 and Figure 1).  
In the co-culture of C. albicans and A. faecalis, there was significant morphological change in 
the C. albicans cells to predominantly hyphae (64.6%) rather than the pseudohyphal (7.4%) and 
yeast (28%) form, possibly due to the interaction with A. faecalis (Table 1 and Figure 1).  
Table 1: Morphology C. albicans in monoculture or coculture with A. faecalis 
 Yeast cells Pseudo hyphal cells Hyphal cells 
Trial 1 
C. albicans 29 8 13 
C. albicans + A. faecalis 10 6 34 
Trial 2 
C. albicans 36 13 1 
C. albicans + A. faecalis 11 3 36 
Trial 3 
C. albicans 34 5 11 
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Figure 1: The morphological state of C. albicans in monoculture and coculture with A. 
faecalis  
 
 Alcaligenes faecalis does not cause a morphological change in Candida glabrata 
 As discussed above, C. glabrata is mainly restricted to yeast form and only changes due 
to extreme circumstances to the pseudohyphal form.  We wanted to take the information from the 
C. albicans/A. faecalis coculture experiments to see if A. faecalis could promote the morphology 
of another Candida species. When C. glabrata is allowed to grow by itself, its morphology is 
exclusively in the yeast (100%) form with no pseudohyphal or hyphal forms (Table 2 and Figure 
2).  When this C. glabrata was mixed with A. faecalis, no morphological change was caused to 
the cells and they also exclusively remained in the yeast (100%) form (Table 2 and Figure 2).  
The cells stayed locked in yeast form.  This suggests that although A. faecalis may have 
inhibitory effects on C. glabrata, it does not change the morphology of the cells or that 
morphology does not play a role in this inhibition.  The inhibition of C. glabrata by A. faecalis 
does not appear to be due to changing the morphology or structures that are found on the 
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Table 2: Morphology C. glabrata in monoculture or coculture with A. faecalis 
 Yeast cells Pseudo hyphal cells Hyphal cells 
Trial 1 
C. glabrata 50 0 0 
C. glabrata + A. faecalis 50 0 0 
Trial 2 
C. glabrata 50 0 0 
C. glabrata + A. faecalis 50 0 0 
Trial 3 
C. glabrata 50 0 0 
C. glabrata + A. faecalis 50 0 0 
 
















MADELYN WHITLOCK 14 
 
Candida mutations in adhesion molecules resists morphological changes caused by A. 
faecalis 
 As discussed above, A. faecalis causes major morphological changes to C. albicans. We 
have previously shown in our lab that the inhibition A. faecalis exerts on Candida is through an 
unknown contact dependent mechanism as cell-free A. faecalis supernatant has no inhibition 
towards Candida. Recently, another laboratory has created strains of C. albicans mutated in 
Agglutin Like Sequences (ALS) that have been shown to be important in C. albicans interactions 
with both human cells and microbial cells. We therefore decided to test one of these mutant 
strains, ALS6, and observe how C. albicans morphology is affected. When C. albicans is 
mutated in the ALS6 gene, it does not respond to A. faecalis induced morphological changes as 
well.  This suggests that when the Candida is mutated it becomes resistant to the inhibitory and 
morphological effects of A. faecalis.  The C. albicans ∆ALS6 monoculture had similar 
morphology arrangements as the wild-type C. albicans in previous experiments with 
predominantly yeast morphology (68%), followed by pseudohyphal and hyphal forms (both at 
16%). Whereas, wild-type C. albicans, when grown with A. faecalis, shifted the morphology to 
hyphal form (68.4%) (Figure 1) the C. albicans ∆ALS6 with A. faecalis has morphologies more 
similar to the monoculture with (74.6%) and hyphal (24.9%)(Table 3 and Figure 3). 
Interestingly, there was a lack of pseudohyphal forms in C. albicans ∆ALS and A. faecalis co-
culture.     
Table 3: Morphology C. albicans ∆ALS6 in monoculture or coculture with A. faecalis 
 Yeast cells Pseudohyphal cells Hyphal cells 
Trial 1 
C. albicans ∆ALS6 37 0 13 
C. albicans ∆ALS6 + A. faecalis 50 0 0 
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Trial 2 
C. albicans ∆ALS6 20 24 6 
C. albicans ∆ALS6 + A. faecalis 25 0 25 
Trial 3 
C. albicans ∆ALS6 45 0 5 
C. albicans ∆ALS6 + A. faecalis 37 0 12 
 
Figure 3: The morphological state of C. albicans ∆ALS6 in monoculture and coculture with 
A. faecalis 
 
Alcaligenes viscolactis does not cause a morphological change in C. albicans 
As we observed morphological changes due to the effects A. faecalis has on C. albicans 
and the C. albicans mutant, it is important to see if other species of Alcaligenes has a similar 
effect on Candida.  Previous work in our laboratory has shown that A. viscolactis also inhibits C. 
albicans on agar and planktonic cultures. In both the monoculture of C. albicans and the 
coculture of C. albicans with A.viscolactis, all (100%) of the cells were in the yeast morphology 
(Table 4 and Figure 4).  These experiments could suggest that A. viscolactis has a inhibitory 
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albicans.  An important aspect that could have an effect on the morphology of C. albicans in this 
experiment is the growing conditions.  While C. albicans grows optimally at both 37⁰ C and 
30⁰ C, temperature can alter morphology of C. albicans with hyphal growth preferring the 37⁰ C 
temperature and yeast morphology growth preferring 30⁰ C.  Additionally, A. viscolactis grows 
optimally at room temperature and is almost completely inhibited at 37⁰ C. Thus, C. albicans 
may not produce any hyphae or pseudohyphae purely due to the temperature that is required for 
the co-culture with A. viscolatis.  
Table 4: Morphology C. albicans in monoculture or coculture with A.viscolactis 
 Yeast cells Pseudo hyphal cells Hyphal cells 
Trial 1 
C. albicans 50 0 0 
C. albicans + A.viscolactis 50 0 0 
Trial 2 
C. albicans 50 0 0 
C. albicans + A.viscolactis 50 0 0 
Trial 3 
C. albicans 50 0 0 
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The observation that the lack of morphological change in C. albicans may be due to the 
temperature that is required for A. viscolactis seems to be supported when C. albicans ∆ALS6 is 
grown in monoculture and coculture with A. viscolactis. In this experiment, all cells remain in 
the yeast form (100%) for both the control and experimental groups. Thus, our understanding of 
the morphology changes in C. albicans cannot be confirmed by A. viscolactis at this time. 
 
Table 5: Morphology C. albicans ∆ALS6 in monoculture or coculture with A. viscolactis 
 Yeast cells Pseudohyphal cells Hyphal cells 
Trial 1 
C. albicans ∆ALS6 50 0 0 
C. albicans ∆ALS6 + 
A.viscolactis 
50 0 0 
Trial 2 
C. albicans ∆ALS6 50 0 0 
C. albicans ∆ALS6 + 
A.viscolactis 
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C. albicans ∆ALS6 50 0 0 
C. albicans ∆ALS6 + 
A.viscolactis 
50 0 0 
 




A. faecalis significantly inhibits both C. albicans and C. glabrata growth in 24h planktonic 
cocultures as evidenced by colony forming units (CFUs). 
 After demonstrating that A. faecalis has and effect on C. albicans morphology, we 
wanted to take the same  microbial combinations and conditions to determine if Alcaligenes 
inhibited planktonic Candida growth. Using cocultures of C. albicans or C. glabrata with A. 
faecalis grown over 24 hours, we assessed the inhibitory effect of A. faecalis on the CFUs of 
Candida. There was a significant inhibition of A. faecalis on C. albicans planktonic growth. This 
inhibition reached an average of 37.3% fewer CFUs over 24 hours as compared to C. albicans 
monoculture controls (Table 6 and Figure 6). This growth inhibition was also observed in C. 











MADELYN WHITLOCK 19 
 
smaller reduction, but was still able to reduce (20.2%) the CFUs over 24 hours (Table 6 and 
Figure 6). 
Table 6: Growth inhibitory effects of A. faecalis on C. albicans and C. glabrata (CFUs)   
 Plate # Number of CFUs 
Trial 1 
C. albicans 5 38 
C. albicans + A. faecalis 3 56 
C. glabrata 5 95 
C. glabrata + A. faecalis 3 170 
Trial 2 
C. albicans 5 75 
C. albicans + A. faecalis 3 5 
C. glabrata 5 53 
C. glabrata + A. faecalis 3 136 
Trial 3 
C. albicans 5 52 
C. albicans + A. faecalis 3 17 
C. glabrata 5 72 



















Figure 6: Growth inhibitory effects of A. faecalis on Candida (CFUs)   
 
  
A. viscolactis significantly inhibits both C. albicans and C. glabrata growth in 24h planktonic 
cocultures as evidenced by colony forming units (CFUs). 
 Similar to the previous A. faecalis growth culture experiment, we wanted to see if the 
closely related A. viscolactis could also inhibit both C. albicans and C. glabrata growth. Table 7 
and Figure 7 show the results of this set of experiments. As in the effects seen with A. faecalis, 
the coculture of A. viscolactis with C. albicans produced the largest reduction in CFUs with a 
decrease of 37.3%. Additionally, there was also a reduction of C. glabrata CFUs (21.6%), just 
not as large a decrease as with C. albicans (Table 7 and Figure 7). These results, in conjunction 
with the previous morphology, may show that morphology, particularly the hyphal form, is more 
susceptible to this inhibition. Since C. glabrata cannot produce hyphae, this may indicate why 
there is not as great a reduction in CFUs. However, we can see that although A. viscolactis 
cannot alter the morphology of C. albicans, most likely due to the temperature requirements, it 
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Table 7: Growth inhibitory effects of A. viscolactis on C. albicans and C. glabrata (CFUs)   
 Plate # Number of CFUs 
Trial 1   
C. albicans 5 57 
C. albicans + A. viscolactis 3 76 
C. glabrata 5 54 
C. glabrata + A. viscolactis 3 126 
Trial 2   
C. albicans 5 14 
C. albicans + A. viscolactis 5 10 
C. glabrata 5 38 
C. glabrata + A. viscolactis 3 156 
Trial 3   
C. albicans 5 10 
C. albicans + A. viscolactis 3 102 
C. glabrata 5 26 
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The concentration of A. faecalis cells does not have an effect on the amount of inhibition 
We have been able to demonstrate that A. faecalis inhibits both C.albicans and C. 
glabrata, but whether the concentration or amount of A. faecalis cells needed to increase this 
inhibition is unknown. We attempted to determine if increasing the concentration of A. faecalis 
cells involved in the interaction will increase the amount of C. albicans inhibition by spotting 
varying increasing concentrations of A. faecalis on lawns of C. albicans and measuring the zones 
of inhibition (ZOI). To do this, we used the same overnight cultures of A. faecalis, made 1000µl 
aliquots, centrifuged the cells and resuspended them in a reduced volume creating 2X, 4X, 8X, 
and 12X concentrations. These concentrations were spotted onto Candida lawns on agar plates, 
incubated for 24 hours and the ZOI measure. Table 8 and Figure 8 show the results of this 
inhibition. After a certain point (4X) there does not seem to be much effect on the amount of 
inhibition seen on C. albicans or C. glabrata.  There is a small increase in ZOI from 2X to 4X, 
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Table 8: A. faecalis Zones of Inhibition on Candida lawns (millimeters) 
Zones of Inhibition 
 2X A.faecalis 4X A.faecalis 8X A.faecalis 12X A.faecalis 
Trial 1 C. albicans  25mm 23mm 27mm 22mm 
C. glabrata 26mm 21mm 27mm 24mm 
Trial 2 C. albicans 16mm 20mm 22mm 23mm 
C. glabrata 20mm 21mm 22mm 21mm 
Trial 3 C. albicans 22mm 28mm 22mm 25mm 
C. glabrata 30mm 24mm 23mm 25mm 
 
Figure 8: A. faecalis Zones of Inhibition on Candida lawns (millimeters) 
 
Discussion 
 The Alcaligenes species, which is commonly found in the water and soil, has inhibitory 
effects on Candida species.  The level of inhibition varies depending on the interaction between 
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faecalis showing the greatest level of inhibition on C .albicans.  The interaction between these 
two microbes causes a morphological change in C. albicans from the typical yeast cell to the 
hyphal cell morphology.  This observation calls into question if the method of inhibition of A. 
faecalis on C. albicans is the changes in morphology.  The concentration of A. faecalis did not 
have a significant impact on the inhibition it causes to C. albicans.  When Candida is mutated, 
particularly in the ALS6 sequence, it seems to resist the morphological changes and stays mostly 
in yeast form.   There was no morphological change, however, observed in the interaction 
between A. faecalis and C. glabrata.  Although not as high of a reduction, inhibition of C. 
glabrata by A. faecalis did occur.  As there were no changes in the morphology of C. glabrata, 
there is no argument for changes in morphology being the method of inhibition by A. faecalis.  
The concentration of A.s faecalis also had no significant impact on the degree of inhibition 
observed on C. glabrata, but A. viscolactis has inhibitory effects on both Candida albicans and 
Candida glabrata.  There is no observable change in morphology of the C. albicans when A. 
viscolactis interacts with C. albicans.  The same observation was made when A. viscolactis 
interacted with mutated C. albicans in the ALS6 gene.  The optimal growing conditions for 
Candida species is at 37, but A. viscolactis, however, grows optimally at room temperature.  
This difference in growing conditions could be a factor that affects the results of these 
experiments.   
 The future of this project would be to look at the genetics of Alcaligenes and Candida 
species and to determine how the inhibition from the Alcaligenes species occurs.  Next steps 
could include pinpointing the genes in C. albicans involved in this interaction with A. faecalis. 
Another aspect to further research would be how Alcaligenes species interact with different C. 
albicans mutated in the ALS family. To date, there are nine different ALS genes (ALS1-ALS9) 
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that C. albicans possesses. Determining if all, none, or specific combinations of these genes are 
essential in the inhibition of Alcaligenes with Candida. 
 The clinical status of treatment of bacterial and fungal infections is problematic in the 
way that microbes easily evolve to be resistant to current antibiotics and antifungals.  The misuse 
of antibiotics led to the development of major pathogens like Methicillin resistant 
Staphylococcus aureus (MRSA) and Clostridium difficile.  In the beginning of antibiotic 
treatment, there were hundreds of antibiotics that could be used and were effective, that number 
has decreased massively and continues to dwindle.  It is important, if not vital, to find alternative 
treatments for bacterial and fungal infections.  This project is one of hundreds that are hoping to 
make the first steps in the direction of discovering an alternative treatment method.  This project 
looks specifically at using one microbe to inhibit another.  The hope is that projects like this one 
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